The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the ...

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

Japanese drugmaker JCR Pharmaceuticals has entered into a joint collaboration, option and license agreement with US biotech Acumen Pharmaceuticals to develop a novel therapeutic candidate for the ...

On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are ...

Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

China-based Jiangsu Hengrui Pharma and US start-up Kailera Therapeutics, which is advancing a broad pipeline of ...

Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic ...

In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost ...

The Bristol Myers Squibb subsidiary RayzeBio has opened a new 77,000-square-foot facility in Indianapolis, Indiana.

US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an ...